After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Akebia Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Akebia Therapeutics Inc is $987.51M. A total of 2.53 million shares were traded on the day, compared to an average of 4.79M shares.
In the most recent transaction, Ostrowski Erik sold 41,314 shares of AKBA for 3.67 per share on Jun 30 ’25. After the transaction, the SVP, CFO, CBO & Treasurer now owns 503,586 company shares. In a previous transaction on Jun 30 ’25, Ostrowski Erik bought 41,314 shares at 3.67 per share.
Among the insiders who sold shares, Malabre Richard C disposed of 15,000 shares on Jun 09 ’25 at a per-share price of $4.01. This resulted in the SVP, Chief Accounting Officer holding 266,914 shares of AKBA after the transaction. In another insider transaction, Malabre Richard C sold 13,334 shares at $3.53 per share on Jun 04 ’25. Company shares held by the SVP, Chief Accounting Officer now total 266,914.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AKBA has a high of $4.08 and a low of $1.07.
As of this writing, AKBA has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.04.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AKBA’s latest balance sheet shows that the firm has $149.80M in Cash & Short Term Investments as of fiscal 2021. There were $136.05M in debt and $261.05M in liabilities at the time. Its Book Value Per Share was $0.09, while its Total Shareholder’s Equity was $74.01M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
